These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1311634

  • 1. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas.
    Leenstra S, Troost D, Westerveld A, Bosch DA, Hulsebos TJ.
    Cancer Res; 1992 Mar 15; 52(6):1568-72. PubMed ID: 1311634
    [Abstract] [Full Text] [Related]

  • 2. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 3. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
    von Deimling A, Bender B, Jahnke R, Waha A, Kraus J, Albrecht S, Wellenreuther R, Fassbender F, Nagel J, Menon AG.
    Cancer Res; 1994 Mar 15; 54(6):1397-401. PubMed ID: 8137236
    [Abstract] [Full Text] [Related]

  • 4. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994 Mar 15; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 5. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
    Lang FF, Miller DC, Koslow M, Newcomb EW.
    J Neurosurg; 1994 Sep 15; 81(3):427-36. PubMed ID: 8057151
    [Abstract] [Full Text] [Related]

  • 6. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 15; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 7. Allelotype of human malignant astrocytoma.
    Fults D, Pedone CA, Thomas GA, White R.
    Cancer Res; 1990 Sep 15; 50(18):5784-9. PubMed ID: 1975510
    [Abstract] [Full Text] [Related]

  • 8. Loss of heterozygosity for loci on chromosome 17p in human malignant astrocytoma.
    Fults D, Tippets RH, Thomas GA, Nakamura Y, White R.
    Cancer Res; 1989 Dec 01; 49(23):6572-7. PubMed ID: 2573417
    [Abstract] [Full Text] [Related]

  • 9. Molecular analysis of genomic abnormalities in human gliomas.
    Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestaña A, Rey JA.
    Cancer Genet Cytogenet; 1994 Apr 01; 73(2):122-9. PubMed ID: 8174086
    [Abstract] [Full Text] [Related]

  • 10. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 11. Somatic mutations of PTEN in glioblastoma multiforme.
    Wang SI, Puc J, Li J, Bruce JN, Cairns P, Sidransky D, Parsons R.
    Cancer Res; 1997 Oct 01; 57(19):4183-6. PubMed ID: 9331071
    [Abstract] [Full Text] [Related]

  • 12. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
    Nakamura H, Yoshida M, Tsuiki H, Ito K, Ueno M, Nakao M, Oka K, Tada M, Kochi M, Kuratsu J, Ushio Y, Saya H.
    Oncogene; 1998 Feb 26; 16(8):1009-19. PubMed ID: 9519875
    [Abstract] [Full Text] [Related]

  • 13. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 14. The retinoblastoma gene is involved in malignant progression of astrocytomas.
    Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu HJ, Benedict WF, Yandell DW, Louis DN.
    Ann Neurol; 1994 Nov 14; 36(5):714-21. PubMed ID: 7979217
    [Abstract] [Full Text] [Related]

  • 15. Instability of microsatellites in human gliomas.
    Dams E, Van de Kelft EJ, Martin JJ, Verlooy J, Willems PJ.
    Cancer Res; 1995 Apr 01; 55(7):1547-9. PubMed ID: 7882363
    [Abstract] [Full Text] [Related]

  • 16. The putative tumor suppressor gene FHIT at 3p14.2 is rarely affected by loss of heterozygosity in primary human brain tumors.
    Frank S, Müller J, Plaschke J, Hahn M, Hampl J, Hampl M, Pistorius S, Schackert G, Schackert HK.
    Cancer Res; 1997 Jul 01; 57(13):2638-41. PubMed ID: 9205070
    [Abstract] [Full Text] [Related]

  • 17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 18. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas.
    von Deimling A, Louis DN, von Ammon K, Petersen I, Wiestler OD, Seizinger BR.
    Cancer Res; 1992 Aug 01; 52(15):4277-9. PubMed ID: 1353411
    [Abstract] [Full Text] [Related]

  • 19. DNA hypermethylation is associated with 17p allelic loss in neural tumors.
    Makos M, Nelkin BD, Chazin VR, Cavenee WK, Brodeur GM, Baylin SB.
    Cancer Res; 1993 Jun 15; 53(12):2715-8. PubMed ID: 8389241
    [Abstract] [Full Text] [Related]

  • 20. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 15; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.